Cargando…
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
Dysregulation of S100A8 is described in many different human tumor types, but its role in prostate cancer is unknown. To evaluate the clinical relevance of S100A8 expression in prostate cancer, a tissue microarray containing 13,665 tumors was analyzed by immunohistochemistry. Cytoplasmic S100A8 stai...
Autores principales: | Minner, Sarah, Hager, Dominik, Steurer, Stefan, Höflmayer, Doris, Tsourlakis, Maria Christina, Möller-Koop, Christina, Clauditz, Till S, Hube-Magg, Claudia, Luebke, Andreas M, Simon, Ronald, Sauter, Guido, Göbel, Cosima, Weidemann, Sören, Lebok, Patrick, Dum, David, Fraune, Christoph, Izbicki, Jakob, Burandt, Eike, Schlomm, Thorsten, Huland, Hartwig, Heinzer, Hans, Haese, Alexander, Graefen, Markus, Heumann, Asmus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698296/ https://www.ncbi.nlm.nih.gov/pubmed/31382165 http://dx.doi.org/10.1016/j.neo.2019.07.003 |
Ejemplares similares
-
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019) -
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019) -
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer
por: Marx, Andreas, et al.
Publicado: (2020) -
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019) -
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020)